SARS‐CoV‐2 reinfection across a spectrum of immunological states
Abstract
Several cases of symptomatic reinfection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) after full recovery from a prior episode have been reported. As reinfection has become an increasingly common phenomenon, an improved understanding of the risk factors for reinfection and the character and duration of the serological responses to infection and vaccination is critical for managing the coronavirus disease 2019 (COVID‐19) pandemic.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jul 01, 2022
- Source ID
- 10.1002/hsr2.554
Entities
People
- Christopher R. Polage
- Elizabeth Petzold
- Ephraim L Tsalik
- Gregory D Sempowski
- Justine M. Mckittrick
- Micah T McClain
- Thomas N. Denny
- Thomas W. Burke
Organizations
- Defense Advanced Research Projects Agency
- Duke University
- Duke University Human Vaccine Institute
- Duke University School of Medicine